Saliva Supernatant Mir-21: a Novel Potential Biomarker for Esophageal Cancer Detection.

Zi-Jun Xie,Gang Chen,Xu-Chao Zhang,Dong-Feng Li,Jian Huang,Zi-Jun Li
DOI: https://doi.org/10.7314/apjcp.2012.13.12.6145
2012-01-01
Asian Pacific Journal of Cancer Prevention
Abstract:OBJECTIVE:To identify whether saliva supernatant miR-21 can serve as a novel potential biomarker in patients with esophageal cancer (EC).METHODS:32 patients with EC and 16 healthy controls were recruited in this study. Total RNA was extracted from saliva supernatant samples for measurement of miR-21 levels using RT-qPCR and relationships between miR-21 levels and clinical characteristics of EC patients were analyzed.RESULTS:miR-21 was significantly higher in the EC than control groups. The sensitivity and specificity were 84.4% and 62.5% respectively. Supernatant miR-21 levels showed no significant correlation with cancer stage, differentiation and nodal metastasis.CONCLUSIONS:Saliva supernatant miR-21 may be a novel biomarker for EC.
What problem does this paper attempt to address?